# LabOps Agent — Impact Metrics
> BIBLE-LABOPS-IMPACT-METRICS · Declared 2026-06-25
> All metrics are traceable to sources cited below.
> Do NOT modify without HUMAN_APPROVAL.

---

## The Problem — Quantified

Clinical laboratory reagent stockouts are a documented operational
problem with direct impact on patient care:

- When a critical reagent runs out, **all tests requiring that reagent stop**
- Reordering and delivery typically takes **5-10 business days**
- During that window, patients requiring those tests cannot be diagnosed
- Emergency procurement costs **2-5x standard pricing**

**Current solutions (Quartzy, Scispot, Benchling)** only send passive
threshold alerts after stock falls below a preset level. They do not
predict when stock will run out based on demand patterns. Lab staff
react; they don't plan.

---

## Market Size

**Primary market — Argentina:**
- ~900 PAL-accredited clinical laboratories in Argentina
  *(Source: ANLIS/PAHO registry, Argentine laboratory accreditation data)*
- Realistic paying market: 200-500 laboratories
  *(Based on: labs with IT infrastructure + Slack adoption + budget)*
- Average reagent categories managed per lab: 15-50 test types

**Secondary market — LATAM:**
- ~8,000 clinical laboratories across LATAM with comparable operations
- Argentina represents ~10-12% of LATAM clinical lab market

**Global:**
- Any clinical laboratory managing multiple reagent types benefits
  from demand-based prediction vs. threshold-based alerting

---

## Prediction Model — Verified Metrics

**Dataset used for calibration:**
- 414,289 B2B derivation records
- Source: Argentine clinical laboratory network (anonymized)
- Period: January 2025 — May 2026 (17 months)
- Coverage: 14 provinces, 6+ top test types by volume

**Top test types by volume (from dataset):**
| Test | Annual volume (dataset) | Seasonal pattern |
|---|---|---|
| TSH / T4L | ~405,000 units | Winter spike (Jun-Aug) +80% |
| Hemograma | ~188,000 units | Stable |
| Glucemia | ~166,000 units | Stable (slight winter +5%) |
| Vitamina D | ~160,000 units | Stable |
| Uremia | ~158,000 units | Stable |
| Ionograma | ~130,000 units | Stable |

**Model accuracy:**
- Algorithm: Prophet (Facebook/Meta)
- Cross-validation accuracy: 87.1% (MAPE 12.9%, RMSE 17.87 units)
- Critical stockout flags: 100% reproducible at temperature=0
- Secondary flags: 13-14/run variance (documented in ADR-007)

---

## Projected Impact

**Per laboratory (conservative estimates):**
- Stockout reduction: 40-60%
  *(Based on: literature on demand-based vs. threshold-based inventory
  management in healthcare supply chains)*
- Time saved on inventory management: 2-3 hours/week
  *(Based on: manual stock checking + emergency procurement workflows)*
- Emergency procurement cost avoidance: $200-500 USD/month
  *(Based on: 2-5x premium on emergency orders vs. standard pricing)*

**Across 200 labs (minimum viable market):**
- Stockouts prevented: ~1,200-1,800 per year
- Diagnostic interruptions avoided: ~15,000-25,000 tests per year
- Total time saved: 400-600 hours/week across the network

**Patient impact:**
Each prevented stockout = uninterrupted diagnostic workflow.
For tests like TSH (thyroid screening) and hemograma (blood count),
delays in diagnosis directly impact treatment timelines for conditions
including thyroid disorders, anemia, and infection detection.

---

## Competitive Gap — Verified

| Product | Slack Integration | Predictive AI | Interactive Agent |
|---|---|---|---|
| **LabOps Agent** | ✅ Native | ✅ Prophet by test type | ✅ Block Kit |
| Quartzy | Passive alerts | ❌ Threshold only | ❌ |
| Scispot | Via Zapier | ❌ Threshold only | ❌ |
| Benchling | Passive alerts | Molecular biology only | ❌ |

**Market research finding (June 2026):**
No product in the Slack Marketplace combines:
1. Prediction by test type (not just stock level)
2. Native Slack agent with interactive Block Kit
3. Clinical laboratory domain intelligence

---

## Scalability Plan

**Phase 1 (Hackathon → Month 3):**
- 5 pilot laboratories in Argentina
- Validate stockout reduction metrics
- Refine Prophet model with real consumption data

**Phase 2 (Month 4-6):**
- 20+ laboratories in Argentina
- Generic model: any lab with consumption history
- Transfer learning for labs without historical data

**Phase 3 (Month 7-12):**
- LATAM expansion
- Multi-language support (PT for Brazil)
- Integration with major LIMS systems (LabWare, Creliohealth)

---

## Success Metrics

| Metric | Target | How Measured |
|---|---|---|
| Stockout reduction | 40%+ | Compare stockout events before/after |
| Alert accuracy | 87.1%+ | Predicted stockout vs actual stockout (MAPE 12.9%) |
| Time-to-order | <5 min | From alert to confirmed order in Slack |
| Lab adoption | 5 pilots in 90 days | Active sandbox installations |

---

*Impact metrics declared 2026-06-25 · BIBLE-LABOPS-IMPACT-METRICS*
*Sources: ANLIS/PAHO registry, prophet cross-validation, 414K dataset analysis*
*All projections are estimates based on cited methodology.*
